Albireo Pharma, Inc.
ALBO · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$37,800 | -$39,949 | -$42,434 | -$10,962 |
| Dep. & Amort. | $124 | $84 | $114 | $107 |
| Deferred Tax | $0 | $0 | $0 | $2,647 |
| Stock-Based Comp. | $3,547 | $3,616 | $3,508 | $2,659 |
| Change in WC | $773 | -$2,903 | -$6,565 | -$11,517 |
| Other Non-Cash | $3,726 | $2,760 | $9,968 | $3,175 |
| Operating Cash Flow | -$29,630 | -$36,392 | -$35,409 | -$13,891 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$40 | -$685 | -$235 | -$279 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$40 | -$685 | -$235 | -$279 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $20,633 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$230 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $121,485 | $1,801 | $4,380 | $370 |
| Financing Cash Flow | $121,485 | $1,801 | $4,380 | $370 |
| Forex Effect | -$310 | -$408 | -$188 | -$984 |
| Net Chg. in Cash | $91,505 | -$35,684 | -$31,452 | -$14,505 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $180,971 | $216,655 | $248,107 | $262,612 |
| End Cash | $272,476 | $180,971 | $216,655 | $248,107 |
| Free Cash Flow | -$29,670 | -$37,077 | -$35,644 | -$14,170 |